Pacific Biosciences Of California Return on Tangible Equity 2010-2024 | PACB

Current and historical return on tangible equity values for Pacific Biosciences Of California (PACB) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Pacific Biosciences Of California Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $-0.31B $-0.20B 109.15%
2024-09-30 $-0.39B $-0.35B 136.69%
2024-06-30 $-0.40B $-0.32B 166.15%
2024-03-31 $-0.30B $-0.26B 144.70%
2023-12-31 $-0.31B $-0.22B 179.01%
2023-09-30 $-0.31B $-0.16B 170.48%
2023-06-30 $-0.32B $-0.18B 168.56%
2023-03-31 $-0.32B $-0.13B 178.27%
2022-12-31 $-0.31B $-0.26B 185.21%
2022-09-30 $-0.30B $-0.19B 265.48%
2022-06-30 $-0.20B $-0.14B 344.30%
2022-03-31 $-0.17B $-0.09B -435.00%
2021-12-31 $-0.18B $-0.03B -136.62%
2021-09-30 $-0.04B $0.02B -16.14%
2021-06-30 $-0.08B $0.26B -30.71%
2021-03-31 $-0.06B $0.28B -30.03%
2020-12-31 $0.03B $0.34B 20.53%
2020-09-30 $-0.05B $0.13B -64.56%
2020-06-30 $-0.05B $0.04B -98.55%
2020-03-31 $-0.05B $0.06B -87.60%
2019-12-31 $-0.08B $0.06B -121.30%
2019-09-30 $-0.12B $0.05B -136.90%
2019-06-30 $-0.11B $0.08B -106.47%
2019-03-31 $-0.11B $0.10B -102.35%
2018-12-31 $-0.10B $0.11B -94.93%
2018-09-30 $-0.09B $0.13B -91.63%
2018-06-30 $-0.09B $0.09B -96.00%
2018-03-31 $-0.09B $0.10B -91.63%
2017-12-31 $-0.09B $0.09B -100.00%
2017-09-30 $-0.09B $0.10B -98.11%
2017-06-30 $-0.09B $0.12B -93.22%
2017-03-31 $-0.08B $0.07B -86.43%
2016-12-31 $-0.07B $0.09B -76.64%
2016-09-30 $-0.06B $0.10B -59.46%
2016-06-30 $-0.04B $0.11B -46.15%
2016-03-31 $-0.03B $0.09B -50.42%
2015-12-31 $-0.03B $0.07B -65.61%
2015-09-30 $-0.05B $0.04B -115.29%
2015-06-30 $-0.06B $0.03B -131.87%
2015-03-31 $-0.07B $0.04B -129.47%
2014-12-31 $-0.07B $0.06B -108.64%
2014-09-30 $-0.06B $0.05B -99.61%
2014-06-30 $-0.08B $0.06B -104.17%
2014-03-31 $-0.08B $0.08B -92.40%
2013-12-31 $-0.08B $0.07B -86.67%
2013-09-30 $-0.08B $0.08B -83.00%
2013-06-30 $-0.09B $0.10B -77.30%
2013-03-31 $-0.09B $0.11B -71.40%
2012-12-31 $-0.10B $0.11B -68.59%
2012-09-30 $-0.10B $0.13B -60.38%
2012-06-30 $-0.10B $0.15B -56.82%
2012-03-31 $-0.10B $0.17B -50.81%
2011-12-31 $-0.11B $0.19B -49.32%
2011-09-30 $-0.12B $0.21B -50.15%
2011-06-30 $-0.13B $0.23B -62.04%
2011-03-31 $-0.15B $0.25B -91.92%
2010-12-31 $-0.14B $0.28B -146.60%
2010-06-30 $-0.09B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.318B $0.154B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $200.815B 87.96
Thermo Fisher Scientific (TMO) United States $152.859B 18.49
Edwards Lifesciences (EW) United States $45.098B 29.57
Alcon (ALC) Switzerland $43.243B 29.22
IDEXX Laboratories (IDXX) United States $41.175B 47.32
DexCom (DXCM) United States $33.592B 51.92
IQVIA Holdings (IQV) United States $24.294B 13.61
STERIS (STE) Ireland $24.256B 26.75
Mettler-Toledo (MTD) United States $23.762B 28.26
Waters (WAT) United States $20.923B 29.52
SONOVA HOLDING (SONVY) Switzerland $19.641B 0.00
Hologic (HOLX) United States $12.421B 13.50
Sysmex ADR (SSMXY) Japan $10.695B 30.34
Penumbra (PEN) United States $10.662B 83.68
Masimo (MASI) United States $8.371B 30.88
Globus Medical (GMED) United States $7.953B 18.65
Teleflex (TFX) United States $5.589B 9.23
Glaukos (GKOS) United States $5.235B 0.00
Integer Holdings (ITGR) United States $4.155B 21.77
TransMedics (TMDX) United States $4.120B 89.57
PROCEPT BioRobotics (PRCT) United States $3.215B 0.00
LivaNova (LIVN) United Kingdom $2.389B 14.23
Veracyte (VCYT) United States $2.231B 31.31
Nihon Kohden (NHNKY) Japan $2.102B 24.11
Elekta AB (EKTAY) Sweden $2.048B 18.41
Alphatec Holdings (ATEC) United States $1.862B 0.00
Tandem Diabetes Care (TNDM) United States $1.512B 0.00
Artivion (AORT) United States $1.237B 115.88
Pulse Biosciences (PLSE) United States $1.109B 0.00
OPKO Health (OPK) United States $1.055B 0.00
Integra LifeSciences Holdings (IART) United States $1.011B 5.38
SiBone (SIBN) United States $0.805B 0.00
IRadimed (IRMD) United States $0.685B 34.75
Mesa Laboratories (MLAB) United States $0.659B 14.41
Beta Bionics (BBNX) United States $0.597B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.590B 9.17
NeuroPace (NPCE) United States $0.560B 0.00
Delcath Systems (DCTH) United States $0.559B 0.00
OrthoPediatrics (KIDS) United States $0.555B 0.00
RxSight (RXST) United States $0.541B 0.00
AxoGen (AXGN) United States $0.537B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.476B 0.00
Treace Medical Concepts (TMCI) United States $0.425B 0.00
AngioDynamics (ANGO) United States $0.372B 0.00
ClearPoint Neuro (CLPT) United States $0.362B 0.00
Semler Scientific (SMLR) United States $0.355B 9.43
Neuronetics (STIM) United States $0.283B 0.00
Tactile Systems Technology (TCMD) United States $0.224B 13.59
Alpha Tau Medical (DRTS) Israel $0.208B 0.00
Sight Sciences (SGHT) United States $0.177B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
LENSAR (LNSR) United States $0.166B 0.00
Accuray (ARAY) United States $0.164B 0.00
908 Devices (MASS) United States $0.162B 0.00
CVRx (CVRX) United States $0.161B 0.00
Inogen (INGN) United States $0.155B 0.00
Anteris Technologies Global (AVR) Australia $0.143B 0.00
KORU Medical Systems (KRMD) United States $0.141B 0.00
Rapid Micro Biosystems (RPID) United States $0.134B 0.00
Lucid Diagnostics (LUCD) United States $0.133B 0.00
Atossa Genetics (ATOS) United States $0.127B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.097B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.60
InspireMD (NSPR) Israel $0.073B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
EDAP TMS S.A (EDAP) France $0.066B 0.00
Biosig Technologies (BSGM) United States $0.062B 0.00
Zomedica (ZOMDF) United States $0.058B 0.00
Hyperfine (HYPR) United States $0.047B 0.00
Vicarious Surgical (RBOT) United States $0.043B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.035B 0.00
Spectral AI (MDAI) United States $0.034B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.019B 0.00
NexGel (NXGL) United States $0.018B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.008B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.23
Longview Acquisition II (LGV) United States $0.000B 0.00